Objectives

After participating in this educational activity, attendees should be able to:
1| Explain the mechanism of action of baxdrostat and its effect on blood pressure

2| Evaluate the efficacy and safety data from the FigHTN trial

3| Review dosing, adverse effects, and key monitoring parameters for baxdrostat

4| Assess the potential role of baxdrostat in patients with chronic kidney disease and uncontrolled hypertension

Presenter(s): 
Maddie Dankocsik, PharmD
PGY2 HSPAL Pharmacy Resident
Baystate Medical Center
 
NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Maddie Dankocsik, PharmDSpeaker/AuthorNo relevant relationships with ineligible companies to discloseNo
Session date: 
09/14/2026 - 2:00pm to 3:00pm EDT
Location: 
Hybrid
United States
See map: Google Maps
Add to calendar: 
  • 1.00 ACPE Contact Hours
  • 1.00 ACPE Technician contact hours
Please login or register to take this course.